69042
Strontium chloride solution
0.1 M
Synonym(s):
Additive Screening Solution 27/Kit-No 78374
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
CAS Number:
MDL number:
UNSPSC Code:
12352302
PubChem Substance ID:
NACRES:
NA.32
Recommended Products
form
liquid
Quality Level
concentration
0.1 M
density
1.01 g/mL at 20 °C
storage temp.
2-8°C
SMILES string
[Sr]
InChI
1S/Sr
InChI key
CIOAGBVUUVVLOB-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
General description
Strontium chloride solution is an additive screening solution of Additive Screening Kit. Additive Screen kit is designed to allow rapid and convenient evaluation of additives and their ability to influence the crystallization of the sample. The Additive Kit provides a tool for refining crystallization conditions.
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Eye Irrit. 2
Storage Class Code
12 - Non Combustible Liquids
WGK
nwg
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Gang Liu et al.
Theriogenology, 113, 78-84 (2018-02-24)
The survival rate of vitrified-thawed ovarian tissues after autotransplantation still needs to be improved. Therefore finding an ideal cryoprectant to reduce the damage to ovaries that caused by vitrification will pave the way for application of ovary cryopreservation on clinics.
J K Badawi
Deutsche medizinische Wochenschrift (1946), 137(33), 1645-1649 (2012-08-10)
Many patients suffering from urological or non-urological malignancies develop bone metastases. One symptom often found is severe skeletal pain which siginificantly lowers the quality of life. Further symptoms are pathological fractures, spinal cord compression and hypercalcemia. The systemic radiopharmaceutical therapy
Tetsuya Taguchi
Clinical calcium, 21(3), 429-438 (2011-03-02)
In metastatic breast cancer the most common metastatic site is bone. Skeletal-related events (SREs) as well as bone pain are well-known characteristics of bone metastasis. Activation of osteoclast is the most important mechanism for the progression of bone metastasis. To
Karen A Autio et al.
Current treatment options in oncology, 13(2), 174-188 (2012-04-25)
Skeletal metastases threaten quality of life, functionality, and longevity in patients with metastatic castration-resistant prostate cancer (mCRPC). Therapeutic strategies for bone metastases in prostate cancer can palliate pain, delay/prevent skeletal complications, and prolong survival. Pharmacologic agents representing several drug classes
Diane Cummins
American journal of dentistry, 23 Spec No A, 3A-13A (2011-02-03)
To provide a brief overview of the diagnosis, epidemiology, etiology and clinical management of dentin hypersensitivity, to discuss technical approaches to relieve sensitivity, with special emphasis on dentin tubule occlusion and the clinical evidence for efficacy of desensitizing toothpastes based
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service